Dexcom Patient Assistance Program for US Patients During the COVID-19 Pandemic

The Dexcom Patient Assistance Program will be available to current  US  customers who have lost their health insurance coverage as a result of the impact of the COVID-19 pandemic.*

For those existing US customers who qualify for participation in the program, Dexcom offers:

• Up to two shipments of 90-days of Dexcom G6 Continuous Glucose Monitoring (CGM) System supplies, with each shipment consisting of one transmitter and three boxes of three sensors
• Reduce patient cost to $45 per 90-day supply shipment

To be eligible to participate in the Dexcom Patient Assistance Program you will need to complete an application by clicking the link below.

*Patients that are eligible for coverage of their Dexcom CGM systems under a federal or state government program (such as Medicare, Medicaid or VA benefits) are not eligible to participate in this Program. Certain terms and conditions will apply to be eligible for participation in the Program, such as the submission of a complete Program application and documentation showing loss of healthcare benefits.